Takara Bio Inc. (TYO:4974)
Japan · Delayed Price · Currency is JPY 1,146.00
-1.00 (-0.09%)
At close: Mar 6, 2026
Takara Bio Market Cap
Takara Bio has a market cap or net worth of 138 billion as of March 6, 2026. Its market cap has increased by 12.68% in one year.
Market Cap
138.00B
Enterprise Value
128.44B
Revenue
44.15B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,146.00
Market Cap Chart
Since December 7, 2004, Takara Bio's market cap has increased from 54.50B to 138.00B, an increase of 153.22%. That is a compound annual growth rate of 4.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 138.00B | 44.15% |
| Dec 30, 2025 | 95.73B | -24.29% |
| Dec 30, 2024 | 126.44B | -16.13% |
| Dec 29, 2023 | 150.76B | -27.34% |
| Dec 30, 2022 | 207.48B | -34.83% |
| Dec 30, 2021 | 318.38B | -4.48% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PeptiDream | 182.26B |
| GNI Group | 173.42B |
| SanBio Company | 161.92B |
| Nxera Pharma | 77.01B |
| Oncolys BioPharma | 75.97B |
| Cuorips | 56.45B |
| Healios K.K. | 54.27B |
| Japan Tissue Engineering | 29.69B |